Sperm and trophoblast are among the few nucleated human cells that do not express HLA class I antigens. DNA methylation, which is proposed to be a tight mechanism of regulation, may be necessary to turn off these genes. We have investigated the transfectability of HLA class I genes and of the genes for the T-cell differentiation antigens Leu-i (CD5) and Leu-2 (CD8) in mouse L cells by using human sperm cells and choriocarcinoma cell lines, tumors of trophoblastic origin, as sources of DNA. It was found that DNA from one choriocarcinoma line (JAR) does not transfect genes for HLA, Leu-1, or Leu-2 and that DNA from two other choriocarcinoma lines (BeWo and Ima) transfects only some of the surface markers. Sperm DNA transfects genes for all the surface antigens tested except Leu-1. DNA from control cells and from the line SCH transfects all the markers studied. Southern blots show that all cell types contain apparently intact genes encoding HLA, Leu-1, and Leu-2 and reveal differences in the DNA methylation patterns of genes from different sources of DNA. We treated JAR (the cell line with the lowest transfecting ability) with 5-azacytidine and obtained demethylation ofits DNA. This demethylated DNA transfects genes for both HLA class I antigens and Leu-2. Further culture of JAR cells in the absence of 5-azacytidine results in remethylation of their DNA and decreased ability to transfect these surface antigens. These findings indicate that DNA methylation affects the efficiency of transfection of surface antigen genes in L cells.
The role of DNA methylation in gene regulation is still unclear (1) . DNA methylation is likely to interfere in a dual manner with protein-mediated regulation, since the state of methylation can determine chromatin conformation in transfected DNA (2) and the structure of chromatin can predetermine sites of methylation in sperm DNA (3) . Functional studies on the role of DNA methylation in gene regulation would be greatly facilitated in systems where proteinmediated regulation does not severely interfere. Transfection of naked genomic DNA in eukaryotic cells appears to be suitable for such studies, since proteins are removed from the DNA during DNA extraction, but DNA methylation is retained (4) . In this paper we have investigated the transfectability of genes for HLA class I antigens and of the T-cell differentiation antigens Leu-1 (CD5) and Leu-2 (CD8) by using DNA isolated from human choriocarcinoma (CC) cell lines and sperm. Sperm and trophoblast (cells of origin of CCs) are apparently among the few nucleated cells in the body that do not express HLA class I antigens (5) (6) (7) . We hypothesized that the genes encoding the antigens studied might be turned off because they are methylated in control regions. Indeed, we found that transfection of specific surface antigens is prevented by DNA methylation.
MATERIALS AND METHODS
Cell DNA Extraction. High molecular weight DNA was obtained from the human CC lines JAR, Ima, BeWo, and SCH (previously called Enami). DNA was also purified from human sperm cells, from the T-cell lymphoma JM, and from peripheral blood leukocytes. Spermatozoa and leukocytes were obtained from the same donor to avoid restriction fragment length polymorphism differences. DNA was extracted either by conventional methods of sodium dodecyl sulfate (SDS)/proteinase K (Boehringer Mannheim) lysis followed by banding on a cesium chloride gradient (8) Immunofluorescence. Fluorescence analyses and sorts were made on a modified fluorescence-activated cell sorter (FACS II, Becton Dickinson), used essentially as described (10) . To improve the detection of transfectants stained with fluorescein-coupled antibodies, subtraction of cell autofluorescence was performed as described (11) .
Antibodies. Fluorescein isothiocyanate-conjugated antiLeu-1 (CD5) and anti-Leu-2a (CD8) antibodies were provided by Becton Dickinson. The anti-Trop-1 (12) and W6/32 (anti-HLA class I, recognizing a framework determinant on HLA-A, -B, and -C molecules) (13) antibodies were conjugated with fluorescein isocyanate by using conventional methods (10) . Cell staining was performed as described (10) .
DNA Blot Analysis. This was performed by the method of Southern (14) . Restriction enzymes were purchased from New England Biolabs and from Boehringer Mannheim. The probes used were pHLA-B7 (15), pBR-i (Leu-2 cDNA) (16), and pTI-2.2 (Leu-1 cDNA) (17).
5-Azacytidine (AzaC) Treatment. JAR cells were cultured in medium with 10 ,tM AzaC for 4 days-i.e., two populationdoubling times-and then cultured in the same medium without AzaC. DNA was extracted at various times after the treatment (5-12 days, [6] [7] [8] weeks, or 5-6 months) (see Table  2 ) and used in transfection experiments.
Abbreviations: AzaC, 5-azacytidine; CC, choriocarcinoma. *Present address: Istituto Mario Negri, Milan, Italy.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Table 1 shows the frequencies of transfection of the surface antigens studied (HLA class I, Leu-1, Leu-2, and Trop-1) with DNA from several CC lines as well as from sperm, leukocytes, and JM (a T-lymphoma cell line).
RESULTS
Interestingly, DNA from JAR cells does not detectably transfect genes for HLA, Leu-1, or Leu-2 antigens. DNA from BeWo and Ima cells transfects only some of the markers. DNA from sperm, which does not express any of the antigens studied as detected by fluorescence-activated cell sorter analysis (data not shown), transfects genes for HLA class I antigens and Leu-2 but not Leu-1. SCH cell, leukocyte, and JM cell DNAs transfect all the markers investigated. All the DNA sources we tested transfect the gene for Trop-1, although this antigen is expressed only on some CC lines. The latter findings are consistent with results we obtained in a murine system: DNA from many mouse tissues that do not express various surface antigens nevertheless transfect L cells with genes for these antigens (9) .
There is a correlation between transfectability of HLA class I and of the T-cell differentiation antigens with expression of HLA class I molecules by the CC lines. Indeed JAR DNA has the lowest transfection efficiency for the markers studied and JAR cells do not express any HLA, whereas SCH cell DNA does transfect all the markers and SCH cells express normal levels of HLA. BeWo and Ima cells express intermediate levels of HLA (6) (Fig. 2) . Although DNA from JAR cells does not transfect HLA and Leu-2 genes, after 4 days growth in AzaC DNA from this cell line efficiently transfects genes for HLA class I and Leu-2, as well as Trop-1 (our positive control). The transfection effi- ciency of the DNA extracted after growth in AzaC was highest 12 days after the treatment and remained considerable after [6] [7] [8] weeks until it finally dropped after 4-6 months ( Table 2 ). The treatment with AzaC was repeated in a second experiment. Transfections of the demethylated DNA at similar times gave similar results. The patterns of demethylation and remethylation of JAR DNA were different in the two experiments (Fig. 2) Direct effects of AzaC on DNA, RNA, and protein synthesis (22) did not influence the outcome of transfections performed with DNA obtained from cells treated with AzaC, since there is essentially no carry-over of the drug to the transfected cells.
DNA methylation is the most likely cause of the low transfection ability we observed since it is a covalent modification of the DNA and it is essentially retained after transfection (5) . A formal alternative explanation is the presence of structural damage in the genes that are not transfectable. This is highly unlikely in sperm cells, since it would imply nonfunctional Leu-1 genes in the germ line while Leu-1 is functional in leukocytes from the same individual. Moreover, it would be necessary to postulate that back mutations caused by AzaC can reactivate HLA and Leu-2 genes in JAR cells. This possibility is not consistent with the high frequency of transfection of the genes studied and with the cycles of reactivation/inactivation that follow AzaC treatments.
No expression of HLA class I, Leu-1, and Leu-2 antigens was detected on the surface of JAR cells at any time after the treatment with AzaC. This confirms that DNA hypomethylation may not be sufficient to cause gene expression (23) .
The findings presented here may have interesting implications for the physiology of trophoblast and sperm. Trophoblast, the histotype of origin of CCs, and sperm are among the few types of nucleated cells in the body that do not express HLA class I (5-7). A tight mechanism of regulation like DNA methylation may be necessary in trophoblast as well as in CC lines to prevent the expression of these genes, since expression may lead to an immune response of the mother against the fetus. On the other hand, sperm DNA efficiently transfects genes for HLA class I, thus indicating that these genes are regulated differently in sperm and in CC cells. Sperm DNA does not transfect the gene for Leu-1. By analogy with the results obtained with the CC lines, methylation is the likely cause of this finding.
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